도움말

A Study on the improvements for the article of Gene Therapy in the 'Bioethics and Safety Acts' in 2008

Vol.3 No.1, 2009.04, 53-68 (16 pages)
Copy
Quick View
Not Available
You cannot read this article since the copyright contract has finished. It will be resumed as soon as possible.
Export
Usage : 672
Citations : 1
분야내 활용도 : 1%
More detail >

· Usage : Full-text article downdloads count since 2010.

· Citations : Cited in the DBpia's articles

· Impact Score : Calculates the article impact score on a basis of the usage in the last 24 months.

Abstract
Due to the success of the treatment for ADA patient, gene therapy has been presented as a new treatment for serious diseases. Nowadays gene therapy is used more than 90 times a year around the world(2006). Though it has many benefits, as many studies has pointed out, it has various kinds of ethical problems, including its scientific uncertainty, clinical risks, and the potential violation of human dignity. The Bioethics and Safety Act has been established in order to address these problems in Korea in 2005. However two provisions relevant to gene therapy in the act are not regarded as proper measure to respond these problems. The aims of this paper is to review legal aspects of gene therapy in the Bioethics and Safety Act in 2008, and to find a way to improve the article of gene therapy in the act.
First of all, vague and ambiguous expression of the definition of gene therapy should be crystallized into the definite one. Second, the gene therapy is in general prohibited, and in particular the gene therapy with respect to a spermatozoon, ovum, embryo or fetus is prohibited. There are three exceptional circumstances which allow gene therapy. The exceptional cases contain serious diseases such as hereditary diseases, cancers, and AIDS which may threaten life or cause any serious disability, and diseases whose gene therapy would be deemed considerably more effective than any other treatment. But, the range of these exceptions is too broad to regulate the use of gene therapy. Third, although gene therapy is not regarded as a tried and reliable remedy yet, the establishment and registration of gene therapy institution is easy and simple. The last, there are two kinds of laws relevant to gene therapy which are the Bioethics and Safety Act and Pharmaceutical Affairs Act. There are some inconsistency and confusions in implementing these two laws. This paper will address legal problems, articulate inconsistencies within these laws, and find better oversight system of gene therapy in Korea.

TOC
Ⅰ. 들어가며
Ⅱ. 생명윤리법상 유전자치료 조항에 대한 분석
Ⅲ. 맺으며
Abstract
Keyword
Cited articles (1)

Please apply for Alerts and check the information by e-mail!

Other articles of first author (12)

Please check the detailed of Hyeon Cheol KIM Identified author!

  • 처음
  •  
  • 이전
  •  
  • 1
  •  
  • 2
  •  
  • 다음
  •  
  • 마지막
Within this Journal (6)

Please check the detailed of Vol.3 No.1!

Recommended Articles (10)

We provide services, 'DBpia Recommended Articles' and 'Customers who used this article also used', that used text mining, usage and citations data.

DBpia Recommended Articles

More recommended articles!

Customers who used this article also used

Metrics

Usage Status

· Usage

· Top 3 institutions list on usage

More detail >
No Top institutions Usage
1 이화여자대학교 57
2 서울대학교 25
3 가톨릭대학교 성심교정 10

Impact Score

· Impact Score

· The article impact score on the subject

More detail >

: %

2016-09
2016-10
2016-11
2016-12
0
20
40
60
80
100
  • 0%
  • 20%
  • 40%
  • 60%
  • 80%
  • 100%

Citations

Detailed Info
Copyright Policy

The copyright of all work are belongs to the original author. The contents of each work shall not be responsible or guarantee. Crawl the metadata of articles do not allowed without agreement.

top